Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
Zealand Pharma anticipates initiation of a Phase 2b clinical trial in H2 2024
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
The companies have initiated Phase 3 studies in patients with high-risk melanoma and non-small cell lung cancer
The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Thermo Fisher has equipped this Centre for Innovation with state-of-the-art platforms such as CellInsight CX7 LZR Pro High Content Screening Platform
Submission based on results from pivotal phase III trial showing all primary endpoints met
Late-breaking data to be featured in an oral presentation at the American Association for Cancer Research (AACR) annual meeting on Monday, April 8 and highlighted as part of the official meeting press program
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Subscribe To Our Newsletter & Stay Updated